Artificial Intelligence

Two major data providers have launched the Sports Data Exchange, an open standard aiming to solve the industry's biggest data headache and unlock innovation.

With fresh capital, the Swedish biotech is scaling its revolutionary platform that decodes cellular communication, fueling a major US expansion.

A new partnership delivers a domestically-made BESS control system, tackling strict federal regulations and securing the US clean energy supply chain.

A strategic merger between Tenet’s AI platform and Crown’s air freight legacy aims to create a unified, end-to-end solution for North American carriers.

As AI coding tools proliferate, a new solution aims to secure the open-source dependencies they ingest, tackling a rapidly expanding attack surface.

The state has the aerospace and robotics muscle, but can it transform its industrial past into a future where it owns the AI-driven space economy?

New pre-clinical data shows engineered immune cells (iMacrophages) can effectively target and destroy ovarian tumors, offering hope for a new treatment era.

Biotech firm Scribe Therapeutics, co-founded by a Nobel laureate, is pioneering a new gene therapy for high cholesterol that silences genes, not cuts them.

With over 80% of AI projects failing, a new diagnostic test from MobiDev aims to help executives understand why and how to salvage their investments.

As stablecoin volume surpasses credit cards, fintech KAST hires a former SEC official to spearhead its push for regulatory legitimacy in the U.S. market.

After dominating the utility sector, tax software firm Lucasys is now signing major oil & gas clients, signaling a strategic shake-up in energy finance.

As threats to GPS mount, NAL Technologies' new ultra-low power ALTM-T module offers a resilient timing solution for power grids and financial markets.

A new system from OSHIMA goes beyond simple defect detection, integrating AI inspection with spreading and cutting for a seamless smart factory workflow.

A new imaging agent could slash the years-long diagnostic delay for endometriosis, offering hope to millions of women suffering from the debilitating condition.

Justt is the first chargeback firm on the Forbes Fintech 50, showing AI is now crucial for merchants fighting a growing $125 billion problem.

Swiss medtech firm CorFlow is tackling a major post-heart attack complication with two pivotal trials, aiming to create a new standard of care.

Pair Team's AI 'Flora' joins a new Medicare program to tackle chronic illness by addressing social needs, a bold move in value-based care.

TIME recognizes Fora's disruptive platform, which empowers thousands of new entrepreneurs to redefine the travel advisor role with AI-supercharged expertise.

A new report reveals a shocking gap: 92% of executives are confident in their AI talent strategy, while only 26% of employees on the ground agree.

Former HHS Secretary Tommy Thompson joins Vector Science & Therapeutics, leveraging his political clout to advance a novel transdermal drug delivery platform.